A team of scientists have published details of how a class of drugs called "HDACis" drive muscle-cell regeneration in the early stages of dystrophic muscles, but fail to work in late stages. The study was led by Pier Lorenzo Puri, M.D., associate professor at Sanford-Burnham Medical Research Institute (Sanford-Burnham), in collaboration with Fondazione Santa Lucia in Rome, Italy. The findings are key to furthering clinical development of HDACis for Duchenne muscular ...Tuesday 15 April 2014
Age Matters in Regenerating Muscle in Duchenne Muscular Dystrophy
A team of scientists have published details of how a class of drugs called "HDACis" drive muscle-cell regeneration in the early stages of dystrophic muscles, but fail to work in late stages. The study was led by Pier Lorenzo Puri, M.D., associate professor at Sanford-Burnham Medical Research Institute (Sanford-Burnham), in collaboration with Fondazione Santa Lucia in Rome, Italy. The findings are key to furthering clinical development of HDACis for Duchenne muscular ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment